Comparative effect of dose escalation of nanocapsulated ivermectin against mange in rabbits
-
Published:2022
Issue:4
Volume:2
Page:8-15
-
ISSN:2703-1322
-
Container-title:German Journal of Veterinary Research
-
language:en
-
Short-container-title:Ger. J. Vet. Res.
Author:
Abdelmoteleb Azza M.,Elmasry Dalia M. A.,Amro Fatma H.,Mahmoud Reham A. A.
Abstract
The present study aimed to investigate the effects of nano-capsulated ivermectin on the liver and kidney function and oxidative status in mite infested-rabbits, compared to ivermectin. Additionally, the ivermectin residue profile in adipose tissue, liver, muscle, and kidney was evaluated. For this purpose, nano-capsulated ivermectin was prepared and characterized using high-resolution transmission electron microscopy (HRTEM) and cytotoxicity assay on Vero cells. To assess the effect of dose escalation of nano-capsulated ivermectin, one-hundred naturally mite-infested male rabbits were divided into four groups (G1-G4; n=25). Rabbits kept in G1 were left untreated (positive control), while rabbits kept in G2 and G3 received subcutaneously 200 and 400 μg/kg body weight ivermectin, respectively, at zero-day and repeated after two weeks of the first injection. Rabbits in G4 were treated with 200 μg/kg nano-capsulated ivermectin at zero day as a single dose. Additionally, twenty-five healthy male rabbits (G0) were used as a negative control. The efficacy was assessed based on clinical manifestations, liver and kidney function, and oxidative stress parameters. Ivermectin residues were measured in fat, liver, muscle, and kidney using high-performance liquid chromatography (HPLC). Results showed that the size of the nano-capsulated ivermectin was 35.4 nm with a narrow size distribution of 0.578 polydispersity indexes. A significant improvement in liver and kidney functions (P<0.05) was observed in G4 received nano-capsulated ivermectin compared with G1, G2, and G3. Moreover, the oxidative stress marker malondialdehyde (MDA) showed significantly lower levels (P<0.05) in rabbits kept in G4. The nano-capsulated ivermectin treatment had the lowest ivermectin residues in edible tissues with the shortest withdrawal duration (14 days) below the maximum residue limits. The study concluded that nano-capsulated ivermectin is the recommended antiparasitic against mites in rabbits.
Publisher
German Multidisciplinary Publishing Center
Subject
Genetics,Animal Science and Zoology
Reference48 articles.
1. Abu Hafsa, S.H., Senbill, H., Basyony, M.M., Hassan, A.A., 2021. Amelioration of Sarcoptic Mange-Induced Oxidative Stress and Growth Performance in Ivermectin-Treated Growing Rabbits Using Turmeric Extract Supplementation. Animals (Basel) 11. doi:10.3390/ani11102984 2. Al-Jassim, K.B., Jawad, A.A.H., Al-Masoudi, E.A., Majeed, S.K., 2016. Histopathological and biochemical effects of ivermectin on kidney functions, lung and the ameliorative effects of vitamin C in rabbits (Lupus cuniculus). Basrah Journal of Veterinary Research 14, 110–124. 3. Ammerman, N.C., Beier-Sexton, M., Azad, A.F., 2008. Growth and maintenance of Vero cell lines. Curr. Protoc. Microbiol. Appendix 4, Appendix 4E. doi:10.1002/9780471729259.mca04es11 4. Arise, R.O., Malomo, S.O., 2009. Effects of ivermectin and albendazole on some liver and kidney function indices in rats. African Journal of Biochemistry Research 3, 190–197. 5. Baynes, R.E., Payne, M., Martin-Jimenez, T., Abdullah, A.R., Anderson, K.L., Webb, A.I., Craigmill, A., Riviere, J.E., 2000. Extralabel use of ivermectin and moxidectin in food animals. J. Am. Vet. Med. Assoc. 217, 668–671. doi:10.2460/javma.2000.217.668
|
|